Artificial Neural Network for Predicting Car Performance Using JNN

In this paper an Artificial Neural Network (ANN) model was used to help cars dealers recognize the many characteristics of cars, including manufacturers, their location and classification of cars according to several categories including: Buying, Maint, Doors, Persons, Lug_boot, Safety, and Overall. ANN was used in forecasting car acceptability. The results showed that ANN model was able to predict the car acceptability with 99.12 %. The factor of Safety has the most influence on car acceptability evaluation. Comparative study method is suitable for the evaluation of car acceptability forecasting, can also be extended to all other areas

Multivariate statistical analysis of urban soil contamination by heavy metals at selected industrial locations in the Greater Toronto area, Canada

A good understanding of urban soil contamination with metals and the location of pollution sources due to industrialization and urbanization is important for addressing many environmental problems. The results are reported here of an analysis of the metals content in urban soils samples next toindustrial locations in the Greater Toronto Area (GTA) in Ontario, Canada. Theanalyzed metals are Cr, Mn, Fe, Ni, Cu, Zn, and Pb. Multivariate geostatistcalanalysis (correlation matrix, cluster analysis, principal component analysis) is used to estimate soil chemical content variability. The correlation matrix exhibits a positive correlation with Mn, Fe, Cu, Zn, Cd, and Pb. The principal component analysis (PCA) displays two components. The first component explains the major part of the total variance and is loaded heavily with Cr, Mn, Fe, Zn,and Pb, and the sources are industrial activities and traffic flows. The second component is loaded with Ni, and Cd, and the sources could be lithology andtraffic flow. The results of the cluster analysis demonstrate three major clusters: 1) Mn-Zn, 2) Pb-Cd-Cu and Cr, 3) Fe-Ni. The geo-accumulation index and the pollution load index are determined and show the main I geovalues to be in the range of 0-1.67; the values indicate that the soil samples studied for industrial locations in the GTA are slightly to moderately contaminated with Cr, Fe, Cu, Zn, and Cd, and moderately contaminated with Pb,while Ni, and Mn fall in class "0". Regarding the pollution load ingindex (PLI), the lowest values are observed at stations 6, 7, 9, 10, 11, 12,25, 27 and 28, while the highest values are recorded for stations 1, 5, 6, 13,14, 16, 17, 18, 20, 22 and 24, and very high PLI readings are seen for stations 5, 13, 16, 17, 18, 22 and 24. These data confirm that the type of industries, especially metallurgical and chemical related ones, in the study area, in addition to high traffic flows, are the main sources for soil pollution in the GTA

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

This prospective open-label pilot study evaluated the effectiveness and safety of adalimumab and the relationship to antibodies against infliximab (IFX) in adult patients with active rheumatoid arthritis (RA) who had been treated previously with IFX and experienced treatment failure owing to lack or loss of response or intolerance. Patients self-administered adalimumab 40 mg subcutaneously every other week for 16 weeks, followed by maintenance therapy for up to Week 56. Measures of effectiveness included American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) response criteria, 28-joint Disease Activity Score, and the Health Assessment Questionnaire Disability Index. Serum IFX concentrations, human antichimeric antibody against IFX (HACA), adalimumab serum concentrations, antiadalimumab antibody, and safety also were assessed. Of the 41 enrolled patients, 37 completed 16 weeks and 30 completed 56 weeks of treatment. Patients experienced clinically meaningful improvements in all measures of RA activity, with greater response rates observed for patients who had experienced loss of initial response to or intolerance of IFX. At Week 16, 46% of patients achieved an ACR20 and 28% achieved an ACR50; 61% achieved an at least moderate and 17% achieved a good EULAR response. Clinical benefit was maintained through Week 56 in all effectiveness parameters. Baseline HACA status did not significantly impact effectiveness. No new safety signals were observed; neither former IFX intolerance status nor baseline HACA status had a clinically relevant impact on adverse event frequency or severity. Adalimumab was effective and well-tolerated in patients with RA who previously failed IFX therapy, irrespective of reason for discontinuation and of HACA status